The objectives of the ESC in the field of Regulatory affairs are:
- To ensure an open dialogue with regulatory authorities related to identified topics
- To share expert advice with regulatory authorities regarding procedures and principles related to cardiovascular regulatory aspects, and in particular :
- contribute to the revision of the regulatory process for cardiovascular devices
- encourage a structure to monitor post-approval studies
- Assist in shaping the design of clinical trials and post marketing surveillance registries
- Engage reflection in new areas currently ill regulated, such as biotech and cell-based therapies
The ESC has also been involved in the work of the EMEA Health Care Professionals Working Group.